Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study

References

• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• PellegritiGFrascaFRegalbutoCSquatritoSVigneriRWorldwide increasing incidence of thyroid cancer: update on epidemiology and risk factorsJ Cancer Epidemiol2013201396521223737785
   PubMedGoogle Scholar
• ChenAYJemalAWardEMIncreasing incidence of differentiated thyroid cancer in the United States, 1988–2005Cancer2009115163801380719598221
   PubMed Web of Science ®Google Scholar
• KazaureHSRomanSASosaJAAggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patientsAnn Surg Oncol20121961874188022065195
   PubMed Web of Science ®Google Scholar
• MorrisLGMyssiorekDImproved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysisAm J Surg2010200445446120561605
   PubMed Web of Science ®Google Scholar
• FerrazCEszlingerMPaschkeRCurrent state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodulesJ Clin Endocrinol Metab20119672016202621593119
   PubMed Web of Science ®Google Scholar
• FaheyTJMolecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodulesYearbook Surg20102010163165
   Google Scholar
• SagaraMYonezawaSNagataKExpression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosisInt J Cancer199984325125710371342
   PubMed Web of Science ®Google Scholar
• SakamotoHYonezawaSUtsunomiyaTTanakaSKimYSSatoEMucin antigen expression in gastric carcinomas of young and old adultsHum Pathol1997289105610659308730
   PubMed Web of Science ®Google Scholar
• NakamoriSOtaDMClearyKRShirotaniKIrimuraTMUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinomaGastroenterology199410623533617905449
   PubMed Web of Science ®Google Scholar
• RahnJJDabbaghLPasdarMHughJCThe importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literatureCancer200191111973198211391575
   PubMed Web of Science ®Google Scholar
• HinodaYIkematsuYHorinochiMIncreased expression of MUC1 in advanced pancreatic cancerJ Gastroenterol200338121162116614714254
   PubMed Web of Science ®Google Scholar
• WreesmannVBSieczkaEMSocciNDGenome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerCancer Res200464113780378915172984
   PubMed Web of Science ®Google Scholar
• MorariECSilvaJRGuilhenACMuc-1 expression may help characterize thyroid nodules but does not predict patients’ outcomeEndocr Pathol201021424224921057891
   PubMed Web of Science ®Google Scholar
• MinHSChoeGKimSWS100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroidMod Pathol200821674875518360353
   PubMed Web of Science ®Google Scholar
• AbrosimovASaenkoVMeirmanovSThe cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpressionEndocr Pathol2007182687517916995
   PubMed Web of Science ®Google Scholar
• XingMBRAF mutation in thyroid cancerEndocr Relat Cancer200512224526215947100
   PubMed Web of Science ®Google Scholar
• NikiforovYENikiforovaMNMolecular genetics and diagnosis of thyroid cancerNat Rev Endocrinol201171056958021878896
   PubMed Web of Science ®Google Scholar
• XingMBRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implicationsEndocr Rev200728774276217940185
   PubMed Web of Science ®Google Scholar
• RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United StatesCancer Res201474112913292124840647
   PubMed Web of Science ®Google Scholar
• LeroyXBuisineMPLeteurtreEMUC1 (EMA): une molécule clé de la carcinogenèse? [MUC1 (EMA): A key molecule of carcinogenesis?]Ann Pathol2006264257266 French17128152
   PubMed Web of Science ®Google Scholar
• WeissMBaruchAKeydarIWreschnerDHPreoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 geneInt J Cancer199666155598608966
   PubMed Web of Science ®Google Scholar
• RenaudFGnemmiVDevosPMUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapseThyroid20142491375138425012490
   PubMed Web of Science ®Google Scholar
• KebebewEWengJBauerJThe prevalence and prognostic value of BRAF mutation in thyroid cancerAnn Surg2007246346647017717450
   PubMed Web of Science ®Google Scholar
• SchroederJAThompsonMCGardnerMMGendlerSJTransgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary glandJ Biol Chem200127616130571306411278868
   PubMed Web of Science ®Google Scholar
• AlamMAhmadRRajabiHKharbandaAKufeDMUC1-C oncoprotein activates ERK→C/EBPbeta signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cellsJ Biol Chem201328843308923090324043631
   PubMed Web of Science ®Google Scholar
• ChenQLiDRenJLiCXiaoZXMUC1 activates JNK1 and inhibits apoptosis under genotoxic stressBiochem Biophys Res Commun2013440117918324055030
   PubMed Web of Science ®Google Scholar
• KogaTKuwaharaILillehojEPTNF-alpha induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implicationAm J Physiol Lung Cell Mol Physiol20072933L693L70117575006
   PubMed Web of Science ®Google Scholar
• IbrahimNKMurrayJLZhouDSurvival advantage in patients with metastatic breast cancer receiving endocrine therapy plus Sialyl Tn-KLH vaccine: post Hoc analysis of a large randomized trialJ Cancer20134757758423983823
   PubMed Web of Science ®Google Scholar
• MacLeanGDReddishMKogantyRRImmunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunol Immunother19933642152228439984
   PubMed Web of Science ®Google Scholar
• MacLeanGDReddishMAKogantyRRLongeneckerBMAntibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccineJ Immunother Emphasis Tumor Immunol199619159688859725
   PubMed Web of Science ®Google Scholar
• MilesDWTowlsonKEGrahamRA randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerBr J Cancer1996748129212968883420
   PubMed Web of Science ®Google Scholar
• HolmbergLASandmaierBMVaccination with Theratope (STn-KLH) as treatment for breast cancerExpert Rev Vaccines20043665566315606349
   PubMedGoogle Scholar
• MilesDPapazisisKRationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancerClin Breast Cancer20033Suppl 4S134S13812620150
   PubMedGoogle Scholar
• MilesDRocheHMartinMTheratope® Study Group. Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancerOncologist20111681092110021572124
   PubMed Web of Science ®Google Scholar
• IbrahimNKMurrayJParkerJFinkeLMilesDGroup TSHumoral immune-response to naturally occurring STn in metastatic breast cancer patients (MBC pts) treated with STn-KLH vaccineJ Clin Oncol200422Suppl 142547
   Web of Science ®Google Scholar
• MusselliCLivingstonPORagupathiGKeyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experienceJ Cancer Res Clin Oncol2001127Suppl 2R20R2611768620
   PubMedGoogle Scholar